Skip to main content

Advertisement

SpringerLink
Log in

The relationship between microRNAs and bladder cancer: are microRNAs useful to predict bladder cancer in suspicious patients?

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Recent studies indicate that circulating micro RNAs (miRNAs) are novel class of non-invasive biomarkers with diagnostic and prognostic information. We evaluated the miRNA expressions in bladder cancer (BC) and their associations with disease diagnosis.

Methods

We profiled the expressions of 379 miRNAs in the plasma samples from patients with non-muscle invasive bladder cancer (NMIBC) (n = 34) and non-malignant urological diseases as a control group (n = 32). Patients were evaluated regarding with age, miRNA expressions, by using descriptive statistics. miRNA expression in extracted RNA was quantified using the NanoString nCounter Digital Analyzer.

Results

The analysis of plasma miRNA levels in the marker identification cohort indicated that plasma (miR-1260a, let-7a-3p miR-196b-5p, miR-196a-5p, miR-99a-5p, miR-615-5p, miR-4301, miR-28-3p, miR-4538, miR-1233-3p, miR-4732-5p, miR-1913, miR-1280) levels were increased in NMIBC patients compared to control subjects. There were no significant differences other parameters studied between groups.

Conclusions

The analysis of serum plasma miRNA (miR-1260a, let-7a-3p miR-196b-5p, miR-196a-5p, miR-99a-5p, miR-615-5p, miR-4301, miR-28-3p, miR-4538, miR-1233-3p, miR-4732-5p, miR-1913, miR-1280) levels could be useful plasma biomarkers for BC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

    Article  PubMed  Google Scholar 

  2. Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL et al (2022) European association of urology guidelines on non–muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ). Eur Urol 81:75–94. https://doi.org/10.1016/j.eururo.2021.08.010

    Article  PubMed  Google Scholar 

  3. Xu W, Zhao Wang Q, Cui Q, Xu R (2011) MicroRNA polymorphisms, MicroRNA pharmacogenomics and cancer susceptibility. Curr Pharmacogenom Person Med 8(4):289–305. https://doi.org/10.2174/187569210793368221

    Article  Google Scholar 

  4. Poli G, Egidi MG, Cochetti G, Brancorsini S, Mearini E (2020) Relationship between cellular and exosomal miRNAs targeting NOD-like receptors in bladder cancer: preliminary results. Minerva Urol e Nefrol. https://doi.org/10.23736/S0393-2249.19.03297-1

    Article  Google Scholar 

  5. Guelfi G, Cochetti G, Stefanetti V, Zampini D, Diverio S, Boni A et al (2018) Next generation sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research. Sci Rep. https://doi.org/10.1038/s41598-018-24236-y

    Article  PubMed  PubMed Central  Google Scholar 

  6. Schwarzenbach H, Nishida N, Calin GA, Pantel K (2014) Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 11:145–156. https://doi.org/10.1038/nrclinonc.2014.5

    Article  CAS  PubMed  Google Scholar 

  7. Cochetti G, Rossi de Vermandois JA, Maulà V, Cari L, Cagnani R, Suvieri C et al (2022) Diagnostic performance of the bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: a single centre, prospective, blinded clinical trial. Urol Oncol Semin Orig Investig 40(3):105.e11-105.e18. https://doi.org/10.1016/j.urolonc.2021.11.001

    Article  CAS  Google Scholar 

  8. Suarez-Cabrera C, Estudillo L, Ramón-Gil E, Martínez-Fernández M, Peral J, Rubio C et al (2022) BlaDimiR: a urine-based miRNA score for accurate bladder cancer diagnosis and follow-up. Eur Urol 82:663–667. https://doi.org/10.1016/j.eururo.2022.08.011

    Article  CAS  PubMed  Google Scholar 

  9. Li R, Chen X, Li X, Huang G, Lu C, Wen Z et al (2022) A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis. Am J Transl Res 14(7):4606–4616

    PubMed  PubMed Central  Google Scholar 

  10. Bay A, Coskun E, Oztuzcu S, Ergun S, Yilmaz F, Aktekin E (2014) Plasma microRNA profiling of pediatric patients with immune thrombocytopenic purpura. Blood Coagul Fibrinolysis. https://doi.org/10.1097/MBC.0000000000000069

    Article  PubMed  Google Scholar 

  11. Le Bot N (2012) miRNAs and cell-cycle control in ESCs. Nat Cell Biol 14(7):658. https://doi.org/10.1038/ncb2544

    Article  CAS  Google Scholar 

  12. Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33(4):1290–1297. https://doi.org/10.1093/nar/gki200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Miyamae M, Komatsu S, Ichikawa D, Kawaguchi T, Hirajima S, Okajima W et al (2015) Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer. Br J Cancer. https://doi.org/10.1038/bjc.2015.366

    Article  PubMed  PubMed Central  Google Scholar 

  14. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA (2009) MicroRNAs—the micro steering wheel of tumour metastases. Nat Rev Cancer 9:293–302. https://doi.org/10.1038/nrc2619

    Article  CAS  PubMed  Google Scholar 

  15. Zhang Q, Miao S, Han X, Li C, Zhang M, Cui K et al (2018) MicroRNA-3619–5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21. Cell Death Dis. https://doi.org/10.1038/s41419-018-0986-y

    Article  PubMed  PubMed Central  Google Scholar 

  16. Zhao F, Zhou LH, Ge YZ, Ping WW, Wu X, Xu XL et al (2019) MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle. J Cell Physiol 234(4):4910–4923. https://doi.org/10.1002/jcp.27288

    Article  CAS  PubMed  Google Scholar 

  17. Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, Enokida H (2013) Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol. https://doi.org/10.1038/nrurol.2013.113

    Article  PubMed  Google Scholar 

  18. Feng Y, Kang Y, He Y, Liu J, Liang B, Yang P et al (2014) MicroRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer. BMC Urol. https://doi.org/10.1186/1471-2490-14-50

    Article  PubMed  PubMed Central  Google Scholar 

  19. Spagnuolo M, Costantini M, Ferriero M, Varmi M, Sperduti I, Regazzo G et al (2020) Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study. J Exp Clin Cancer Res. https://doi.org/10.1186/s13046-020-01550-w

    Article  PubMed  PubMed Central  Google Scholar 

  20. Margue C, Reinsbach S, Philippidou D, Beaume N, Walters C, Schneider JG et al (2015) Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer? Oncotarget. https://doi.org/10.18632/oncotarget.3661

    Article  PubMed  PubMed Central  Google Scholar 

  21. da Silva Gomes PR, Candido P, Ghazarian V, Camargo JA, Guimarães VR, Gonçalves GL et al (2021) Can increased expression of miR-Let-7c reduce the transition potential of high-grade urothelial carcinoma? Mol Biol Rep 48(12):7947–7952. https://doi.org/10.1007/s11033-021-06825-9

    Article  CAS  PubMed  Google Scholar 

  22. Boubaker NS, Spagnuolo M, Trabelsi N, Said R, Gurtner A, Regazzo G et al (2020) miR-143 expression profiles in urinary bladder cancer: correlation with clinical and epidemiological parameters. Mol Biol Rep 47(2):1283–1292. https://doi.org/10.1007/s11033-019-05228-1

    Article  CAS  PubMed  Google Scholar 

  23. Tölle A, Jung M, Rabenhorst S, Kilic E, Jung K, Weikert S (2013) Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer. Oncol Rep 30(4):1949–1956. https://doi.org/10.3892/or.2013.2621

    Article  CAS  PubMed  Google Scholar 

  24. Carney MC, Tarasiuk A, Diangelo SL, Silveyra P, Podany A, Birch LL et al (2017) Metabolism-related microRNAs in maternal breast milk are influenced by premature delivery. Pediatr Res 82(2):226–236. https://doi.org/10.1038/pr.2017.54

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Faversani A, Favero C, Dioni L, Pesatori AC, Bollati V, Montoli M et al (2021) An EBC/plasma miRNA signature discriminates lung adenocarcinomas from pleural mesothelioma and healthy controls. Front Oncol. https://doi.org/10.3389/fonc.2021.643280

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ghafour AA, Odemis DA, Tuncer SB, Kurt B, Saral MA, Erciyas SK et al (2021) High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma. J Ovarian Res. https://doi.org/10.1186/s13048-021-00878-x

    Article  PubMed  PubMed Central  Google Scholar 

  27. Hussain SA, Deepak KV, Nanjappa DP, Sherigar V, Nandan N, Suresh PS et al (2021) Comparative expression analysis of tRF-3001a and tRF-1003 with corresponding miRNAs (miR-1260a and miR-4521) and their network analysis with breast cancer biomarkers. Mol Biol Rep 48(11):7313–7324. https://doi.org/10.1007/s11033-021-06732-z

    Article  CAS  PubMed  Google Scholar 

  28. Chen CJ, Zhang Y, Zhang L, Weakley SM, Yao Q (2011) MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med 15(1):14–23. https://doi.org/10.1111/j.1582-4934.2010.01219.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Tsai MM, Wang CS, Tsai CY, Huang CG, Lee KF, Huang HW et al (2016) Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer. Eur J Cancer 64:137–148. https://doi.org/10.1016/j.ejca.2016.05.007

    Article  CAS  PubMed  Google Scholar 

  30. Lu YC, Chang JTC, Huang YC, Huang CC, Chen WH, Lee LY et al (2015) Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer. Clin Biochem 48(3):115–121. https://doi.org/10.1016/j.clinbiochem.2014.11.020

    Article  CAS  PubMed  Google Scholar 

  31. Zhang C, Yao C, Li HP, Wang GY, He XJ (2014) Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas. Int J Mol Sci 15(4):6544–6555. https://doi.org/10.3390/ijms15046544

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ren W, Wu S, Wu Y, Liu T, Zhao X, Li Y (2019) MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2. Cell Death Dis. https://doi.org/10.1038/s41419-019-1530-4

    Article  PubMed  PubMed Central  Google Scholar 

  33. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. https://doi.org/10.1016/j.cell.2007.04.040

    Article  PubMed  PubMed Central  Google Scholar 

  34. El Tayebi HM, Hosny KA, Esmat G, Breuhahn K, Abdelaziz AI (2012) MiR-615–5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. FEBS Lett 586(19):3309–3316. https://doi.org/10.1016/j.febslet.2012.06.054

    Article  CAS  PubMed  Google Scholar 

  35. Du J, Zhang G, Qiu H, Yu H, Yuan W (2019) The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615–5p/fibronectin 1 pathway. Cell Mol Biol Lett. https://doi.org/10.1186/s11658-019-0198-1

    Article  PubMed  PubMed Central  Google Scholar 

  36. Guan X, Zong Z, Liu Y, Chen S, Wang L, Zhao Y (2019) circPUM1 promotes tumorigenesis and progression of ovarian cancer by sponging miR-615–5p and miR-6753–5p. Mol Ther Nucleic Acids 18:882–892. https://doi.org/10.1016/j.omtn.2019.09.032

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Huang Z, Zhang L, Zhu D, Shan X, Zhou X, Qi LW et al (2017) A novel serum microRNA signature to screen esophageal squamous cell carcinoma. Cancer Med 6(1):109–119. https://doi.org/10.1002/cam4.973

    Article  CAS  PubMed  Google Scholar 

  38. Silva CMS, Barros-Filho MC, Wong DVT, Mello JBH, Nobre LMS, Wanderley CWS et al (2021) Circulating let-7e-5p, mir-106a-5p, mir-28–3p, and mir-542–5p as a promising microrna signature for the detection of colorectal cancer. Cancers (Basel). https://doi.org/10.3390/cancers13071493

    Article  PubMed  PubMed Central  Google Scholar 

  39. Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafà R et al (2012) Strand-specific miR-28–5p and miR-28–3p have distinct effects in colorectal cancer cells. Gastroenterology 142(4):886-896.e9. https://doi.org/10.1053/j.gastro.2011.12.047

    Article  CAS  PubMed  Google Scholar 

  40. Pospisilova S, Pazzourkova E, Horinek A, Brisuda A, Svobodova I, Soukup V et al (2016) MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection. Neoplasma 63(5):799–808. https://doi.org/10.4149/neo_2016_518

    Article  CAS  PubMed  Google Scholar 

  41. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. https://doi.org/10.1038/nrg2634

    Article  PubMed  PubMed Central  Google Scholar 

  42. Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS et al (2012) MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS ONE 7(10):e46743. https://doi.org/10.1371/journal.pone.0046743

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Piepoli A, Tavano F, Copetti M, Mazza T, Palumbo O, Panza A et al (2012) Mirna expression profiles identify drivers in colorectal and pancreatic cancers. PLoS ONE 7(3):e33663. https://doi.org/10.1371/journal.pone.0033663

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Xu LM, Li LQ, Li J, Li HW, Shen QB, Ping JL et al (2015) Upregulation of MiR-1280 expression in non-small cell lung cancer tissues. Chin Med J (Engl) 128(5):670–673. https://doi.org/10.4103/0366-6999.151672

    Article  CAS  PubMed  Google Scholar 

  45. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G et al (2007) Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67(24):11612–11620. https://doi.org/10.1158/0008-5472.CAN-07-5019

    Article  CAS  PubMed  Google Scholar 

  46. Medina PP, Nolde M, Slack FJ (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467(7311):86–90. https://doi.org/10.1038/nature09284

    Article  CAS  PubMed  Google Scholar 

  47. Gholipour N, Ohradanova-Repic A, Ahangari G (2018) A novel report of MiR-4301 induces cell apoptosis by negatively regulating DRD2 expression in human breast cancer cells. J Cell Biochem. https://doi.org/10.1002/jcb.26577

    Article  PubMed  Google Scholar 

  48. Hindle AG, Thoonen R, Jasien JV, Grange RMH, Amin K, Wise J et al (2019) Identification of candidate miRNA biomarkers for glaucoma. Invest Ophthalmol Vis Sci 60(1):134. https://doi.org/10.1167/iovs.18-24878

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Urh K, Žlajpah M, Zidar N, Boštjančič E (2021) Identification and validation of new cancer stem cell-related genes and their regulatory micrornas in colorectal cancerogenesis. Biomedicines 9(2):179. https://doi.org/10.3390/biomedicines9020179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Yoshikawa Y, Fukunaga M, Takahashi J, Shimizu D, Masuda T, Mizushima T et al (2023) Identification of the minimum combination of serum microRNAs to predict the recurrence of colorectal cancer cases. Ann Surg Oncol 30(1):233–243. https://doi.org/10.1245/s10434-022-12355-w

    Article  PubMed  Google Scholar 

  51. Liu J, Yoo J, Ho JY, Jung Y, Lee S, Hur SY et al (2021) Plasma-derived exosomal miR-4732–5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer. J Ovarian Res. https://doi.org/10.1186/s13048-021-00814-z

    Article  PubMed  PubMed Central  Google Scholar 

  52. Zhou J, Xu L, Yang P, Lu Y, Lin S, Yuan G (2021) The exosomal transfer of human bone marrow mesenchymal stem cell-derived miR-1913 inhibits osteosarcoma progression by targeting NRSN2. Am J Transl Res 13(9):340

    Google Scholar 

  53. Byun YJ, Piao XM, Jeong P, Kang HW, Seo SP, Moon SK et al (2021) Urinary microrna-1913 to microrna-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer. Investig Clin Urol. https://doi.org/10.4111/icu.20200488

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Private Yuzyil Gebze Hospital, Sultan Orhan Mahallesi, Ilyasbey Cd. No:38, 41400, Gebze, Kocaeli, Turkey

    Mehmet Kaba & Samed Verep

  2. Department of Urology, Fırat University Medical Faculty, Elazıg, Turkey

    Necip Pirinççi

  3. Department of Urology, Van Yuzuncuyil University Dursun Odabası Medical Center, Van, Turkey

    Murat Demir

  4. Department of Pediatry, Okan University Hospital, Section of Pediatric Endocrinology, Istanbul, Turkey

    Sultan Kaba

  5. Department of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey

    Serdar Oztuzcu

Authors
  1. Mehmet Kaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Necip Pirinççi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Murat Demir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sultan Kaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Serdar Oztuzcu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Samed Verep
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samed Verep.

Ethics declarations

Conflict of interest

All authors have no conflict of interest.

Ethical approval

The study was conducted after Ethics Committee approval of Yuzuncu Yil University Dursun Odabası Medical Center (B.30.2.YYU.0.01.00.00/90) was granted and written informed consent was obtained from patients. The protocol of this study complies with good medical and laboratory practices and recommendations of Helsinki's Declaration of Biomedical Research.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 168 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaba, M., Pirinççi, N., Demir, M. et al. The relationship between microRNAs and bladder cancer: are microRNAs useful to predict bladder cancer in suspicious patients?. Int Urol Nephrol 55, 2483–2491 (2023). https://doi.org/10.1007/s11255-023-03666-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-023-03666-2

Keywords

Search

Navigation